Citation Impact
Citing Papers
Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
2011
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
2013
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
2017 Standout
Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection
2017
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Melioidosis
2018 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
2011
Insight into the Role of Wnt5a-Induced Signaling in Normal and Cancer Cells
2014
Genetically engineered T cells for cancer immunotherapy
2019
Delivery technologies for cancer immunotherapy
2019 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
A holobiont birth narrative: the epigenetic transmission of the human microbiome
2014
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
2012
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery
2022 StandoutNobel
ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
2012
Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded
2010
Ror‐family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases
2009
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
2010
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
2010
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Human mesenchymal stem cells - current trends and future prospective
2015
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Monoclonal Antibody-Based Immunofluorescence Microscopy for the Rapid Identification of Burkholderia pseudomallei in Clinical Specimens
2013
Works of Roya Ghods being referenced
Accurate Sensitivity of Quantum Dots for Detection of HER2 Expression in Breast Cancer Cells and Tissues
2012
Microenvironment of the feto–maternal interface protects the semiallogenic fetus through its immunomodulatory activity on dendritic cells
2007
Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
2008
Conjugation of Monoclonal Antibodies to Super Paramagnetic Iron Oxide Nanoparticles for Detection of her2/neu Antigen on Breast Cancer Cell Lines.
2009
Isolation and partial characterization of human amniotic epithelial cells: the effect of trypsin.
2014
Comparison of the Photobleaching and Photostability Traits of Alexa Fluor 568- and Fluorescein Isothiocyanate- conjugated Antibody.
2011